This company has been marked as potentially delisted and may not be actively trading. Vital Therapies (VTL) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock VTL vs. SLS, CYBN, RNAZ, DERM, KRRO, ALDX, ACRS, EPRX, GLSI, and SLNShould you be buying Vital Therapies stock or one of its competitors? The main competitors of Vital Therapies include SELLAS Life Sciences Group (SLS), Cybin (CYBN), TransCode Therapeutics (RNAZ), Journey Medical (DERM), Korro Bio (KRRO), Aldeyra Therapeutics (ALDX), Aclaris Therapeutics (ACRS), Eupraxia Pharmaceuticals (EPRX), Greenwich LifeSciences (GLSI), and Silence Therapeutics (SLN). These companies are all part of the "medical" sector. Vital Therapies vs. SELLAS Life Sciences Group Cybin TransCode Therapeutics Journey Medical Korro Bio Aldeyra Therapeutics Aclaris Therapeutics Eupraxia Pharmaceuticals Greenwich LifeSciences Silence Therapeutics SELLAS Life Sciences Group (NASDAQ:SLS) and Vital Therapies (NASDAQ:VTL) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, earnings, valuation, profitability, community ranking, media sentiment and dividends. Which has better valuation and earnings, SLS or VTL? SELLAS Life Sciences Group has higher revenue and earnings than Vital Therapies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSELLAS Life Sciences Group$1M188.58-$37.34M-$0.38-4.97Vital TherapiesN/AN/A-$41.47MN/AN/A Which has more volatility and risk, SLS or VTL? SELLAS Life Sciences Group has a beta of 2.34, meaning that its stock price is 134% more volatile than the S&P 500. Comparatively, Vital Therapies has a beta of 3.51, meaning that its stock price is 251% more volatile than the S&P 500. Does the media prefer SLS or VTL? In the previous week, SELLAS Life Sciences Group had 1 more articles in the media than Vital Therapies. MarketBeat recorded 1 mentions for SELLAS Life Sciences Group and 0 mentions for Vital Therapies. SELLAS Life Sciences Group's average media sentiment score of 0.49 beat Vital Therapies' score of 0.00 indicating that SELLAS Life Sciences Group is being referred to more favorably in the media. Company Overall Sentiment SELLAS Life Sciences Group Neutral Vital Therapies Neutral Is SLS or VTL more profitable? Vital Therapies' return on equity of -235.33% beat SELLAS Life Sciences Group's return on equity.Company Net Margins Return on Equity Return on Assets SELLAS Life Sciences GroupN/A -629.46% -178.65% Vital Therapies N/A -235.33%-182.35% Does the MarketBeat Community favor SLS or VTL? Vital Therapies received 359 more outperform votes than SELLAS Life Sciences Group when rated by MarketBeat users. Likewise, 74.40% of users gave Vital Therapies an outperform vote while only 55.56% of users gave SELLAS Life Sciences Group an outperform vote. CompanyUnderperformOutperformSELLAS Life Sciences GroupOutperform Votes1055.56% Underperform Votes844.44% Vital TherapiesOutperform Votes36974.40% Underperform Votes12725.60% Do insiders & institutionals hold more shares of SLS or VTL? 17.4% of SELLAS Life Sciences Group shares are held by institutional investors. Comparatively, 15.5% of Vital Therapies shares are held by institutional investors. 1.4% of SELLAS Life Sciences Group shares are held by company insiders. Comparatively, 33.9% of Vital Therapies shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. SummarySELLAS Life Sciences Group beats Vital Therapies on 6 of the 11 factors compared between the two stocks. Get Vital Therapies News Delivered to You Automatically Sign up to receive the latest news and ratings for VTL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VTL vs. The Competition Export to ExcelMetricVital TherapiesPharmaceutical Preparations IndustryMedical SectorNASDAQ ExchangeMarket Cap$39.01M$6.47B$5.33B$8.31BDividend YieldN/A2.64%5.20%4.10%P/E RatioN/A8.4026.7219.60Price / SalesN/A258.84395.56117.96Price / CashN/A65.8538.3234.62Price / Book3.176.416.764.50Net Income-$41.47M$143.73M$3.23B$248.40M Vital Therapies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VTLVital TherapiesN/A$0.92+0.1%N/A-27.6%$39.01MN/A0.0010SLSSELLAS Life Sciences Group0.2351 of 5 stars$1.75+7.4%N/A+23.1%$162.64M$1M-2.5410High Trading VolumeCYBNCybin2.7362 of 5 stars$7.50+11.6%$86.00+1,046.7%N/A$161.08MN/A-1.7150Positive NewsHigh Trading VolumeRNAZTransCode Therapeutics2.6478 of 5 stars$6.70-17.9%$280.00+4,079.1%-100.0%$156.39MN/A0.009Positive NewsEarnings ReportHigh Trading VolumeDERMJourney Medical1.8668 of 5 stars$6.75-2.6%$9.88+46.3%+92.1%$155.95M$56.13M-7.1890Gap UpKRROKorro Bio1.9496 of 5 stars$15.71+4.0%$102.43+552.0%-70.5%$147.53M$4.82M-1.6670Gap DownALDXAldeyra Therapeutics2.2329 of 5 stars$2.42+12.0%$9.50+292.6%-41.9%$144.95MN/A-2.4915Trending NewsAnalyst UpgradeAnalyst RevisionACRSAclaris Therapeutics2.8728 of 5 stars$1.30-0.8%$10.00+669.2%+9.6%$140.77M$17.78M-2.50100Positive NewsEPRXEupraxia Pharmaceuticals2.1186 of 5 stars$3.90+1.6%$10.50+169.2%+28.3%$139.81MN/A-5.4229GLSIGreenwich LifeSciences1.1977 of 5 stars$10.18+4.5%$39.00+283.1%-27.4%$135.13MN/A-12.723Earnings ReportSLNSilence Therapeutics3.4669 of 5 stars$4.96+13.5%$33.83+582.1%-79.2%$130.79M$27.70M-3.16100 Related Companies and Tools Related Companies SLS Competitors CYBN Competitors RNAZ Competitors DERM Competitors KRRO Competitors ALDX Competitors ACRS Competitors EPRX Competitors GLSI Competitors SLN Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VTL) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vital Therapies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vital Therapies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
